LabMed
Pulmonary Alveolar Proteinosis (PAP)
-
At a Glance
-
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
-
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
-
What Lab Results Are Absolutely Confirmatory?
At a Glance
Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by diffuse alveolar accumulation of surfactant proteins and phospholipids. Pulmonary alveolar proteinosis occurs four times more frequently in males than females, most commonly in those 20-50 years of age, and is marked by dyspnea and a typically nonproductive cough. Pulmonary alveolar proteinosis may be idiopathic (primary), associated with lung infections, malignant neoplasms, AIDS, or secondary to inhalation of foreign materials, including insecticides, silica, aluminum, titanium oxide and indium-tin oxide. A neonatal form has been observed in infants with a genetic deficiency of surfactant-associated protein B (SP-B).
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Most PAP patients are either deficient of GM-CSF or possess neutralizing antibodies to GM-CSF. These findings may occur in serum and/or bronchoalveolar lavage (BAL) fluid. Currently, GM-CSF and anti-GM-CSF tests are not widely available and are not well-standardized. Demonstration of floccular, eosinophilic, periodic acid-Schiff (PAS)-positive alveolar material in BAL fluid or lung biopsy tissue remains the diagnostic sine qua non. A series of transbronchial biopsies of affected lung segments is usually sufficient to allow for a diagnosis.
Association of PAP with insecticides or inorganic dust exposures is made on the basis of a careful history. Decreased alveolar macrophage levels of the transcription factor, peroxisome proliferator-activated receptor-gamma (PPAR-gamma), have been documented in some patients, but clinical assays for PPAR-gamma are not routinely available.
The most important follow-up tests in PAP patients are studies to rule out unusual infections (e.g., Pneumocystis carinii, Nocardia asteroides, and Mycobacterium avium-intracellulare.)
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
Adequate diagnostic lung tissue is required to make a diagnosis of PAP. The pathologist should be alerted to facilitate PAS stain preparation.
What Lab Results Are Absolutely Confirmatory?
Pulmonary alveolar proteinosis is a diagnosis made on the basis of biopsy findings.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Renal and Urology News Articles
- Hemodialysis Facility Practices Linked to Patient Outcomes
- Guidelines Updated for Pulmonary Arterial Hypertension in Adults
- Dialysis Staff-Initiated CPR Ups Outcomes in Cardiac Arrest
- Cinacalcet May Delay Surgery for Secondary Hyperparathyroidism
- Peritoneal Dialysis Superior for Easing Post-PTx Hungry Bone Syndrome
- Radium-223 Use in mCRPC Differs By Race
- Brachytherapy for Favorable-Risk Prostate Cancer Continues to Decline
- Kidney Damage in Younger Adults Tied to NSAID Use
- Abiraterone, Prednisone With Androgen Deprivation Therapy Show Durable Efficacy in Metastatic Castration-Naive Prostate Cancer
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Anemia
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetes
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Hemodialysis
- Hyperkalemia
- Hyperphosphatemia
- Hypertension
- Hyperuricemia
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Transplantation